interCLICK Announces Appointment of Steven D. Rubin, Member of The Frost Group, To Advisory Board

Ad Operations OnlineNoted Investor Dr. Phillip Frost Acquires a Position in interCLICK Through Private Transaction

NEW YORK – interCLICK, Inc. (the “Company”) (OTCBB: ICLK), a leading behavioral targeting company, announced that it has appointed Steven D. Rubin to its Advisory Board effective immediately. Mr. Rubin is a member of The Frost Group, LLC, a successful private investment firm based in Miami.

Since its formation in October 2006, the Frost Group has invested over $160 million in various companies and technologies in the United States and abroad. Dr. Frost is currently Chairman of Ladenburg Thalmann Financial Services Inc. (NYSE AMEX: LTS), OPKO Health, Inc. (NYSE AMEX: OPK), PROLOR Biotech (OTCBB: PBTH) and is the Vice Chairman of Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA).

“I am pleased to acquire through a private sale an equity investment position in interCLICK, as the Company has demonstrated extraordinary growth to date despite a challenging environment for advertising-related companies,” said Dr. Frost. “I believe that the Company through its investments in technology and marketing is well positioned to continue this growth.”

“I look forward to helping interCLICK continue its goal of becoming the leading ad network in the country,” said Mr. Rubin. “It has built an excellent foundation and I believe that the management team has the technology, customer relationships and platform to continue the growth it has exhibited despite a tough economic environment.”

Mr. Rubin has served as Executive Vice President-Administration and as a director of Opko Health, Inc. (NYSE AMEX: OPK) since March, 2007. Mr. Rubin served as the Senior Vice President, General Counsel and Secretary of IVAX Corporation from August 2001 until September 2006. Before joining IVAX, from January 2000 to August 2001, Mr. Rubin served as the Senior Vice President, General Counsel and Secretary of privately-held Telergy, Inc., a provider of business telecommunications and diverse optical network solutions. Mr. Rubin currently also serves on the board of directors of Modigene Inc., (now PROLOR Biotech, Inc. (OTCBB: PBTH) a development stage biopharmaceutical company, Safe Stitch Medical, Inc., a medical device company (OTCBB: SFES), Dreams, Inc. (NYSE AMEX: DRJ) a manufacturer and provider of licensed sports products, Kidville, Inc., a provider of development education and entertainment services for children (OTCBB:KVIL), Non-Invasive Monitoring Systems, Inc., a medical device company (OTCBB: NIMU), Cardo Medical, Inc., an early-stage orthopedic medical device company specializing in designing, developing and marketing reconstructive joint devices and spinal surgical devices (OTCBB:CDOM), Castle Brands, Inc., a developer and marketer of premium brand spirits (NYSE AMEX: ROX), and Neovasc, Inc., a company developing and marketing medical specialty vascular devices (TSXV:NVC). Mr. Rubin holds a B.A. in Economics from Tulane University and a J.D. from the University of Florida.

“I am gratified that an accomplished investor such as Dr. Frost has recognized through his investment our accomplishments to date in the relatively short time since we have been a public company and has demonstrated his confidence in the future direction of the Company, said Michael Mathews, interCLICK’s Chief Executive Officer. “I look forward to working closely with his team as we enter the next phase of our growth.”

About The Frost Group, LLC

The Frost Group, LLC, is a private investment firm based in Miami. The Frost Group is led by Dr. Frost, and includes Jane Hsiao, Ph.D., Rao Uppaluri, Ph.D., and Mr. Rubin, a team that has been together in various capacities for over 23 years. Since its formation in October 2006, the Frost Group has invested over $160 million in various companies and technologies in the United States and abroad. These investments, which range from small minority investments to controlling majority stakes, span a wide range of innovative and technology platforms in the areas of pharmaceuticals, diagnostic devices, medical devices, development education and entertainment for children, telecommunications, sports licensing, aircraft leasing, fixed based aircraft operations, software for seismic data analysis, and new materials for computer chips.

About interCLICK

interCLICK, Inc. operates the interCLICK Network, an online advertising platform that combines advanced behavioral targeting with complete data and inventory transparency, allowing advertisers to identify and track their desired audience on an unprecedented level. interCLICK offers advanced proprietary demographic, behavioral, contextual, geographic and retargeting technologies across a network of name brand publishers to ensure the right message is delivered to a precise audience in a brand friendly environment. For more information about the interCLICK Network, visit http://www.interclick.com.